| Item | Details |
|---|---|
| Title | Distribution, Phytochemical Insights, and Cytotoxic Potential of the Sesbania Genus: A Comprehensive Review of Sesbania grandiflora, Sesbania sesban, and Sesbania cannabina |
| Authors | Fatma Alzahraa Mokhtar ,Mariam Ahmed ,Aishah Saeed Al Dhanhani ,Serag Eldin I. Elbehairi ,Mohammad Y. Alfaifi 4,5ORCID,Ali A. Shati ,Amal M. Fakhry Amal M. Fakhry |
| Journal Name | Pharmaceuticals |
| Issue Number | Pharmaceuticals 2025, 18(1), 64 |
| Pages | From 18 to 64 |
| Publication Year | 2025 |
| DOI | https://doi.org/10.3390/ph18010064 |
Abstract
This review evaluates the cytotoxic potential of the Sesbania genus, with a focus on Sesbania sesban, Sesbania grandiflora, and Sesbania cannabina. These species, known for their diverse phytochemical compositions, exhibit notable cytotoxic effects that suggest their utility in natural cancer treatments. Compounds such as quercetin, kaempferol, and sesbagrandiforian A and B have been highlighted for their strong antioxidant and antiproliferative effects, further emphasizing their therapeutic potential. The genus Sesbania exhibits a wide range of in vitro and in vivo bioactivities. Extensive research on S. grandiflora has uncovered mechanisms such as the activation of caspase cascades and the induction of apoptosis, attributed to its rich content of flavonoids and alkaloids. Notably, sesbanimides derived from S. grandiflora seeds have demonstrated potent cytotoxic effects by disrupting mitochondrial function. While S. sesban and S. cannabina have been less extensively studied, early findings highlight their potential through the inhibition of key cancer pathways and the identification of bioactive compounds such as galactomannan derivatives and 2-arylbenzofurans. Notably, the galactomannan derivatives from S. s
